Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	14.61B
Revenue (ttm)	525.75M
Net Income (ttm)	170.51M
Shares Out	137.40M
EPS (ttm)	1.25
PE Ratio	84.75
Forward PE	66.44
Dividend	0.80 (0.75%)
Ex-Dividend Date	May 29, 2025

Volume	225,396
Average Volume	254,825
Open	106.69
Previous Close	106.80
Day's Range	105.97 - 107.60
52-Week Range	92.55 - 166.00
Beta	0.04
RSI	40.78
Earnings Date	Aug 22, 2025

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patches; bovine pericardial valves, as well as pulmonary artery valved pipeline, outflow tract single flap patches, etc. Its products are used in heart valv...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 611
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2024, SHA:688198's revenue was 501.88 million, an increase of 35.41% compared to the previous year's 370.64 million. Earnings were 146.33 million, an increase of 27.02%.